Edgewell (EPC) Q2 2026 earnings review

Divestiture Complete, But Core Margins Are Bleeding

Management hailed Q2 as a 'strong second quarter' that exceeded expectations, but the underlying data paints a cautionary picture of the newly simplified company. With Feminine Care moved to discontinued operations, the continuing business saw organic sales fall 2.4% and Adjusted EPS drop 13% to $0.60. The core issue is severe margin compression: a 420-basis-point hit from inflation and tariffs completely erased the company's productivity gains. The North American turnaround continues to lag, dragging down global volumes. Maintaining full-year guidance now requires a steep, high-risk acceleration in the second half.

๐Ÿ‚ Bull Case

Grooming Portfolio Shines

The Grooming segment is accelerating, posting 6.3% volume growth driven by the Cremo brand, proving that targeted brand investments are paying off in key niches.

International Pricing Power

International markets remain stable, delivering 1.0% organic growth fueled by favorable pricing in Wet Shave and Sun Care, partially offsetting North American weakness.

๐Ÿป Bear Case

Severe Margin Compression

Adjusted gross margin collapsed 310 basis points to 43.4%. Cost savings are failing to keep pace with core inflation, tariffs, and elevated promotional spending.

Negative Operating Leverage

Wet Shave sales grew 3.0% on a reported basis, yet segment profit plummeted 27.7%. Top-line gains are currently destroying bottom-line value.

โš–๏ธ Verdict: ๐Ÿ”ด

Bearish. Despite the optimistic PR narrative, declining organic volumes, collapsing Wet Shave profitability, and an increasingly back-half loaded guidance plan present significant execution risks.

Key Themes

CONCERNNEW๐Ÿ”ด๐Ÿ”ด

Wet Shave Profit Collapse Contradicts Positive Narrative

Despite management's claim of 'momentum' and 'improved execution', the Wet Shave segment showed severe negative operating leverage. While reported segment sales rose 3.0% to $294.1M, segment profit plunged 27.7% to $33.7M. This reversing profit trend in Edgewell's largest segment points to highly dilutive promotional discounting and an inability to pass costs through to consumers.

CONCERNNEW๐Ÿ”ด

Macro Pressures Overpower Cost Controls

Edgewell executed well on internal cost controls, delivering 220 basis points of productivity savings. However, this was entirely overwhelmed by a decelerating macro environment: 420 basis points of core inflation and tariffs stripped away these gains. The result was a sharp drop in adjusted gross margin from 46.5% to 43.4%.

DRIVER๐ŸŸข

Cremo Drives Grooming Outperformance

A distinct bright spot is the Grooming sub-segment, which is accelerating. Driven by significant volume growth in the Cremo brand, Grooming grew 6.3%. This validates the company's strategy of allocating capital to higher-growth, higher-margin categories following the Feminine Care divestiture.

CONCERN๐Ÿ”ด

Restructuring Bill Keeps Growing

The cost of simplifying the portfolio and operations is escalating. Management raised their full-year estimate for pre-tax restructuring charges from $65M to $90M. The company booked $23M in restructuring charges in Q2 alone to consolidate Wet Shave operations, pressuring near-term GAAP profitability.

Other KPIs

H1 Adjusted SG&A as % of Sales21.7%

Decelerating efficiency. Adjusted SG&A for the six months rose to 21.7% from 21.4% a year ago. In Q2 specifically, it increased by 50 basis points to 20.1%, driven by higher consulting and corporate expenses offsetting lower people costs.

H1 Operating Cash Flow-$71.6 million

Stable but negative. Cash used in operations worsened slightly from -$70.5M in the prior year period. The decline is largely driven by lower earnings from continuing operations, partially mitigated by working capital timing.

Guidance

FY26 Adjusted EPS$1.70 - $2.10

Stable guidance, but carries heavy execution risk. With H1 Adjusted EPS coming in at just $0.44, reaching the $1.90 midpoint requires generating $1.46 in the second half. This implies a massive, hockey-stick acceleration that depends on near-perfect execution of the U.S. commercial turnaround.

FY26 Organic Net Sales-1.0% to +2.0%

Stable vs prior guidance. With H1 organic sales down 1.6%, achieving the midpoint (+0.5%) demands an immediate reversal to positive growth in Q3 and Q4, hinging largely on a successful Sun Care season and international momentum.

FY26 Adjusted Gross MarginUp ~50 basis points

Decelerating from the previous +60 bps target due to FX headwinds. After a disastrous 310 bps contraction in Q2, forecasting full-year expansion means management expects a dramatic easing of inflation/tariffs or major price hikes to hit in the second half.

Key Questions

Wet Shave Margin Mechanics

Wet Shave sales rose 3% but segment profit fell nearly 28%. How much of this margin degradation was driven by permanent promotional discounting to defend market share versus temporary supply chain or input cost spikes?

The Path to Gross Margin Expansion

Full-year guidance implies gross margins will end up 50 bps higher than last year, despite Q2 shrinking by 310 bps. What specific, locked-in pricing actions or cost rolloffs give you confidence in this severe back-half reversal?

Escalating Restructuring Costs

You raised the full-year restructuring charge estimate by nearly 40% to $90 million. What specific new projects necessitated this increase, and how does this change the expected payback period for your operational consolidation?